遗传学与分子生物学杂志

抽象的

Editorial note on Metabolic syndrome..

Thirunahari Alekhya

The metabolic syndrome is a grouping of metabolic risk factors for heart disease and insulin resistance. Recently, a simple, fast, non-invasive, and realistic screening method was created to identify people who are at high risk of developing type-2 diabetes in the future. The Finnish Type-2 Diabetes Risk Score (FINDRISC) is one of these methods that has been commonly used and validated for detecting unknown diabetes and MS in a variety of populations, mainly Caucasian. Type-2 diabetes and cardiovascular disease diagnosis is overdue, and complications are unavoidable.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。